Skip to content

Clinical trials

Terminated Respiratory Distress Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Status: Terminated Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20055
20061
20072
20082
20095
20102
20113
20121
20131
20152
20163
20171
20191
202018
20216
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Neonatal Research Network5
Massachusetts General Hospital3
Windtree Therapeutics3
Chiesi Farmaceutici S.p.A.2
Johns Hopkins University2
National Heart, Lung, and Blood Institute (NHLBI)2
University of Colorado, Denver2
APR Applied Pharma Research s.a.1
Alan Fujii1
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome61
COVID-1917
Acute Lung Injury13
Pneumonia8
Respiratory Insufficiency8
Coronavirus Infections7
Cytokine Release Syndrome6
Premature Birth6
Hypertension, Pulmonary3
Lung Diseases3

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.